MAR 20, 2015 10:44 AM PDT

Alzheimer's Drug Slows Cognitive Decline

WRITTEN BY: Judy O'Rourke
Biogen Idec Inc, Cambridge, Mass, says aducanumab, its new Alzheimer's drug under development shows signs of slowing the decline of a small number of patients with early indications and mild cases of the disease, according to The Boston Globe.

The company says its testing yielded "statistically significant" evidence the drug slows the decline of certain patients and reduced amyloid plaque in the brain (implicated in the development of Alzheimer's symptoms).
Beta-amyloid is chemically
Biogen says it plans to advance the drug compound to late-stage clinical trials, with FDA approval, and would start to enroll patients later this year.

The newspaper reports the company presented more detailed study results at the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders.

Pharma giant Eli Lilly & Co is also working on an experimental drug for the disease.

More than 5 million Americans suffer from Alzheimer's. Treatments are available to help mitigate symptoms, but there is presently no cure for the disease.

[Source: The Boston Globe]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
SEP 12, 2018
Neuroscience
SEP 12, 2018
Think Young to Stay Young: Aging and Attitude
You're as young as you feel is a wise old saying, but what if it's true? Chronological age is easy to measure. Count up how many years, months or d...
SEP 24, 2018
Drug Discovery
SEP 24, 2018
Further Challenges in Alzheimer Drug Development
Scientists at Trinity College Dublin performed a large-scale international study involving the treatment of Alzheimer's disease, which was published in...
SEP 26, 2018
Videos
SEP 26, 2018
Sydney Brain Bank and CTE
Chronic Traumatic Encephalopathy (CTE), which is caused by repeated blows to the head, results in a unique form of dementia that includes irrational anger,...
OCT 16, 2018
Genetics & Genomics
OCT 16, 2018
Lab-grown Neurons Help Uncover the Genetic Changes Underlying Mental Illness
Developing therapeutics that will effectively relieve mental illness means understanding what is causing those disorders in the first place....
OCT 30, 2018
Cannabis Sciences
OCT 30, 2018
Marijuana Withdrawal Syndrome
The perception of marijuana's safety is prevalent among chronic users. Dr. Samuel Wilkinson and colleagues from the Department of Psychiatry at Ya...
NOV 15, 2018
Drug Discovery
NOV 15, 2018
Treating Restless Leg Syndrome (RLS)
A common condition of the nervous system, Restless Leg Syndrome (RLS) is the overwhelming urge to move the legs. Usually unpleasant symptoms, many RLS pati...
Loading Comments...